Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial.
Lancet Glob Health
; 5(1): e60-e68, 2017 01.
Article
em En
| MEDLINE
| ID: mdl-27840069
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Quinina
/
Clindamicina
/
Artemisininas
/
Etanolaminas
/
Fluorenos
/
Amodiaquina
/
Antimaláricos
Tipo de estudo:
Clinical_trials
/
Guideline
Limite:
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
País como assunto:
Africa
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article